Nasus Pharma Ltd Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Nasus Pharma Ltd (NSRX) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of -$0.01 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-03-25
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|
| 2025-12-31 | -$0.01 20-F · filed 2026-03-25 | |
| 2025-06-30 | -$0.01 6-K · filed 2025-12-29 | |
| 2024-12-31 | $0.00 20-F · filed 2026-03-25 | |
| 2024-06-30 | $0.00 6-K · filed 2025-12-29 | |
| 2023-12-31 | $0.00 20-F · filed 2026-03-25 |